Literature DB >> 15753011

Molecular diagnosis of human papillomavirus (HPV) infections.

Anco Molijn1, Berhard Kleter, Wim Quint, Leen-Jan van Doorn.   

Abstract

Human papillomaviruses (HPVs) comprise more than 100 genotypes. The mucosal types can be divided into high-risk and low-risk (LR) types depending on the associated disease risk. HPV infection is mainly diagnosed by molecular methods, since reliable serological tools are not available and culture of the virus is not possible. Accurate molecular diagnostic techniques that can be used to inform patient management and follow-up after treatment are now available for detection and identification of HPV. The diagnosis of HPV infections in patients at risk of disease in a clinical setting requires a different approach from that used for epidemiological studies, vaccination trials and natural history studies. This review describes the different molecular methods available for HPV detection and genotyping and their possible clinical utility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753011     DOI: 10.1016/j.jcv.2004.12.004

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  59 in total

Review 1.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

2.  Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes.

Authors:  Sa Deepak; Kr Kottapalli; R Rakwal; G Oros; Ks Rangappa; H Iwahashi; Y Masuo; Gk Agrawal
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

3.  Rapid genotyping of human papillomavirus by post-PCR array-based hybridization techniques.

Authors:  Anke Pierik; Chris Zwanenburg; Elna Moerland; Dirk Broer; Henk Stapert; Adriaan J C van den Brule
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

Review 4.  Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review.

Authors:  Sarah M Tiggelaar; Margaret J Lin; Raphael P Viscidi; Jia Ji; Jennifer S Smith
Journal:  J Adolesc Health       Date:  2012-02       Impact factor: 5.012

5.  Type-specific detection of human papillomaviruses in Kazakh esophageal squamous cell carcinoma by genotyping both E6 and L1 genes with MALDI-TOF mass spectrometry.

Authors:  Hong-Chao Dong; Xiao-Bin Cui; Liang-Hai Wang; Man Li; Yao-Yuan Shen; Jian-Bo Zhu; Cheng-Fang Li; Jian-Ming Hu; Shu-Gang Li; Lei Yang; Wen-Jie Zhang; Yun-Zhao Chen; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 6.  Immunoprevention of human papillomavirus-associated malignancies.

Authors:  Joshua W Wang; Chein-Fu Hung; Warner K Huh; Cornelia L Trimble; Richard B S Roden
Journal:  Cancer Prev Res (Phila)       Date:  2014-12-08

7.  Anal dysplasia screening: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2007-06-01

8.  Type-specific detection of 30 oncogenic human papillomaviruses by genotyping both E6 and L1 genes.

Authors:  Junping Peng; Lei Gao; Junhua Guo; Ting Wang; Ling Wang; Qing Yao; Haijun Zhu; Qi Jin
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

9.  Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma.

Authors:  Giuseppina Cantarella; Matthias Liniger; Armando Zuniga; John T Schiller; Martin Billeter; Hussein Y Naim; Reinhard Glueck
Journal:  Vaccine       Date:  2009-02-05       Impact factor: 3.641

10.  Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline.

Authors:  Mark Schiffman; Gary Clifford; Franco M Buonaguro
Journal:  Infect Agent Cancer       Date:  2009-06-01       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.